SCHEMBL12745925

SCHEMBL12745925

CSc1ccccc1-c1ccc2c(c1)C(=O)NS2(=O)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 12/20 0.54
▸ CA9 Q16790 12/20 0.54
▸ CA2 P00918 10/20 0.54
▸ CA1 P00915 7/20 0.54
▸ CA7 P43166 6/20 0.54
▸ KDM4E B2RXH2 3/20 0.54
▸ USP2 O75604 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ BCHE P06276 1/20 0.54
▸ CA4 P22748 1/20 0.54
▸ CA6 P23280 1/20 0.54
▸ CA5A P35218 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ CA14 Q9ULX7 1/20 0.54
▸ CA5B Q9Y2D0 1/20 0.54
▸ CHEK1 O14757 1/20 0.49
▸ DAPK3 O43293 1/20 0.49
▸ MAP4K4 O95819 1/20 0.49
▸ RET P07949 1/20 0.49
▸ PIM1 P11309 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12745887 0.79 CA12 (0.63) CA12CA9CA2CA1CA7
SCHEMBL12745909 0.75 CA9 (0.54) CA12CA9CA2CA1CA7
SCHEMBL12746149 0.74 VEGFA (0.41) KDM4ELMNAKMT2AALDH1A1ALOX5AP
SCHEMBL23600959 0.74 CLK4 (0.51) CA12CA9CA2CA1CA7
Saccharin SCHEMBL27961842 0.72 CA12 (0.92) CA12CA9CA2CA1CA7
Saccharin SCHEMBL29109711 0.72 CA12 (0.92) CA12CA9CA2CA1CA7
Saccharin SCHEMBL6033672 0.72 CA12 (1.00) CA12CA9CA2CA1CA7
Saccharin SCHEMBL6049140 0.72 CA12 (1.00) CA12CA9CA2CA1CA7
Saccharin SCHEMBL7073018 0.72 CA12 (1.00) CA12CA9CA2CA1CA7
Saccharin SCHEMBL4777123 0.72 CA12 (1.00) CA12CA9CA2CA1CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110071178-A1 Methods and Compounds for Modulating Cannabinoid Activity NORTHEASTERN UNIVERSITY (US) 2011-03-24 — — US disclosed
US-20110071178-A1 Methods and Compounds for Modulating Cannabinoid Activity NORTHEASTERN UNIVERSITY (US) 2011-03-24 — — US disclosed
US-20110039874-A1 MONOACYLGLYCEROL LIPASE INHIBITORS FOR MODULATION OF CANNABINOID ACTIVITY NORTHEASTERN UNIVERSITY (US) 2011-02-17 — — US disclosed
US-20110039874-A1 MONOACYLGLYCEROL LIPASE INHIBITORS FOR MODULATION OF CANNABINOID ACTIVITY NORTHEASTERN UNIVERSITY (US) 2011-02-17 — — US disclosed
WO-2009052320-A1 METHODS AND COMPOUNDS FOR MODULATING CANNABINOID ACTIVITY NORTHEASTERN UNIVERSITY (US) 2009-04-23 — — WO disclosed
WO-2009052319-A1 MONOACYLGLYCEROL LIPASE INHIBITORS FOR MODULATION OF CANNABINOID ACTIVITY NORTHEASTERN UNIVERSITY (US) 2009-04-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110039874-A1 MONOACYLGLYCEROL LIPASE INHIBITORS FOR MODULATION OF CANNABINOID ACTIVITY MGLL, FAAH, FAAH2 CA12 3728/4885CA9 2936/4885CA2 2091/4885
US-20110071178-A1 Methods and Compounds for Modulating Cannabinoid Activity FAAH, FAAH2, CNR2 CA12 2645/4885CA9 2397/4885CA2 1564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback